Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
01/2014
01/07/2014US8623928 Polymers of intrinsic microporosity containing tetrazole groups
01/03/2014WO2014005098A2 Compositions and methods for treating or preventing pneumovirus infection and associated diseases
01/03/2014WO2014003124A1 Novel amide derivative and salt thereof
01/03/2014WO2014001363A1 Novel tetrazole derivatives and their use as potassium channel modulators
01/03/2014CA2877941A1 Compositions and methods for treating or preventing pneumovirus infection and associated diseases
01/02/2014US20140005239 Compositions and Methods for Treating or Preventing Pneumovirus Infection and Associated Diseases
01/02/2014US20140005176 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
01/01/2014CN102627615B Novel compound L-4-terazine-phenylalanine, preparation method and application thereof
12/2013
12/26/2013US20130345429 Process and intermediate compounds useful in the preparation of statins
12/25/2013EP2675792A1 Substituted aminobutyric derivatives as neprilysin inhibitors
12/25/2013CN103467409A Substituted tetrazole carboxylic acid compounds and application thereof
12/25/2013CN103467408A Tetrazole carboxylic acid compounds and application thereof
12/25/2013CN103467407A Tetrazole carboxylic acid compounds and application thereof
12/25/2013CN103467406A Halogen-substituted tetrazole carboxylic acid compounds, and preparation method and application thereof
12/25/2013CN103467405A Tetrazole carboxylic acid compounds, and preparation method and application thereof
12/25/2013CN103467404A Method for removing acids out of cyclotetramethylene tetranitramine crude product with superheated water
12/25/2013CN103467403A Method for removing inorganic insoluble substances out of cyclotetramethylene tetranitramine crude product with superheated water
12/25/2013CN103467402A Method for removing acetone insoluble substances out of cyclotetramethylene tetranitramine crude product with superheated water
12/25/2013CN103467395A Solid-phase synthetic method of amantadine derivative
12/25/2013CN101835737B Spiro-ring compound and use thereof for medical purposes
12/25/2013CN101735106B Method for preparing biphenyl compound
12/24/2013CA2666910C Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use
12/19/2013WO2013187327A1 Method for producing 1h-tetrazole derivative
12/19/2013WO2013187325A1 Method for producing azide compound, and method for producing 1h-tetrazole derivative
12/19/2013US20130336949 Tetrazole compounds for reducing uric acid
12/18/2013CN102382071B Technology for preparing 1H-tetrazoleacetic acid with deamination reduction method
12/18/2013CN102351805B Method for preparing, separating and refining 5-amino-1H-tetrazol-1-ylacetic acid
12/17/2013US8609721 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
12/17/2013CA2626454C Difluorophenol derivatives and their use
12/12/2013US20130331420 Tetrazole compounds and methods of making and using same
12/12/2013US20130330366 Neprilysin inhibitors
12/12/2013US20130330365 Neprilysin inhibitors
12/11/2013CN103435567A Valsartan refining method
12/11/2013CN101918379B Platinum complex compound and utilization of the same
12/10/2013US8604083 Method for the treatment of metabolic disorders
12/10/2013CA2495442C Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same
12/04/2013EP2668169A1 Tetrazole compounds and methods of making and using same
12/04/2013CN101622231B 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
12/03/2013US8598206 Trypsin-like serine protease inhibitors, and their preparation and use
12/03/2013US8598181 Modulators of ATP-binding cassette transporters
12/03/2013CA2530302C Novel aminobenzophenone compounds
11/2013
11/28/2013WO2013174843A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxylic thioamides and use thereof as herbicides
11/28/2013US20130317232 Alternative to tetrazene
11/28/2013US20130317044 Novel carboxylic acid derivatives, their preparation and use
11/28/2013US20130317001 N-substituted benzamides and methods of use thereof
11/27/2013CN102924396B Method for crystal transformation from alpha-HMX to beta-HMX
11/27/2013CN102417486B Method for synthesizing valsartan
11/27/2013CN101768035B Method for preparing and recovering aromatic methyl diphenyl compound
11/20/2013EP2664617A1 Method of making a 2,6-diaryl piperidine derivative
11/20/2013EP2220029B1 Benzamide compounds and their use as prostaglandin E4 receptor agonists
11/20/2013CN103402989A Tetrazole compounds and methods of making and using same
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/19/2013US8586536 Neprilysin inhibitors
11/05/2013US8575205 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
11/05/2013CA2491994C Modulators of the glucocorticoid receptor
10/2013
10/31/2013WO2013160701A1 Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide
10/31/2013WO2002064559A3 Thrombin inhibitors
10/31/2013US20130289047 Heteroarylthio derivatives and analogues
10/30/2013CN103373969A Phenyl imidazole ring-substituted amide compounds as well as preparation method and application for same
10/30/2013CN101323610B Preparation of trityl group candesartan cilexetil intermediate
10/30/2013CN101133010B Process and intermediate compounds useful in preparation of statins
10/29/2013US8569528 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
10/29/2013US8569302 Inhibitors of flaviviridae viruses
10/24/2013WO2013158597A1 (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
10/24/2013WO2013157528A1 Bicyclic compound
10/24/2013US20130281705 Compounds for the treatment of metabolic disorders
10/23/2013EP2651900A1 Neprilysin inhibitors
10/23/2013EP2651896A1 Neprilysin inhibitors
10/23/2013CN103360334A Aqueous-phase synthesis method of 5-phenyl-1H-tetrazole
10/23/2013CN103360333A Preparation method of high-purity cyclen
10/22/2013US8563586 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
10/17/2013WO2013154793A1 F2 derivatives as antibacterial agents
10/17/2013US20130274230 (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
10/16/2013CN103351354A Synthesizing method of 1-methyl-5-aminotetrazole
10/16/2013CN103351353A Aqueous phase synthesis method of 5-methyl tetrazole
10/16/2013CN103351352A Novel synthetic method for 5-phenyl tetrazole
10/16/2013CN103351351A Preparation process for TAT
10/10/2013WO2013152359A1 Novel tetrazines and method of synthesizing the same
10/10/2013US20130267571 Terpenoid analogues and uses thereof for treating neurological conditions
10/08/2013US8552062 Methods for the treatment of metabolic disorders such as diabetes
10/01/2013US8546448 3-substituted compounds for reducing uric acid
10/01/2013US8546389 Viral polymerase inhibitors
10/01/2013US8546374 Amino-tetrazoles analogues and methods of use
09/2013
09/25/2013EP2640689A1 Substituted carbamoylcycloalkyl acetic acid derivatives as nep inhibitors
09/25/2013CN103328436A New aryl-benzocycloalkyl amide derivatives
09/25/2013CN103319426A Preparation method of temperature-resisting lead-free and barium-free primary explosive 5-nitramino tetrazole calcium
09/25/2013CN102329276B Method for recovering valsartan mother liquid
09/24/2013US8540966 Contrast agents endowed with high relaxivity
09/24/2013CA2611609C Ampa receptor potentiators
09/19/2013WO2013137075A1 Compound, method for producing compound, and method for purifying compound
09/19/2013US20130243698 Radical polarizing agents for dynamic nuclear polarization
09/18/2013CN103304504A Anti-diabetic compound, as well as preparation method and application thereof
09/18/2013CN103304503A Anti-diabetic compound, as well as preparation method and application thereof
09/18/2013CN103304502A Anti-diabetic compound, as well as preparation method and application thereof
09/18/2013CN103304501A Anti-diabetic compound, as well as preparation method and application thereof
09/18/2013CN103304500A Novel anti-diabetic compound, as well as preparation method and application thereof
09/18/2013CN103304499A Anti-diabetic compound, as well as preparation method and application thereof
09/18/2013CN103304498A Anti-diabetic compound, as well as preparation method and application thereof
09/18/2013CN102395556B Carboxylate compound and use thereof
09/18/2013CN102153481B Application of thionyl chloride and alcohol as selective deacylation reagents for N-aryl fatty amide or N-heterocyclic fatty amide
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 97